Skip to main content
. 2021 Apr 14;14:105. doi: 10.1186/s12920-021-00952-9

Table 1.

Oncologists responses concerning the clinical utility of NGS multigene analysis in various tumor types

Oncologists responses Tumor histology
Lung (%) Colorectal (%) Breast (%) Ovarian (%) Pancreas (%) Prostate (%) Rare/unknown (%)
Useful 60.66 65.57 45.90 65.57 50.82 50.82 85.25
Useful in the metastatic setting 39.34 29.51 34.43 14.75 44.26 39.34 14.75
Not useful 0.00 4.92 9.84 9.84 0.00 0.00 0.00
No opinion/response 0.00 0.00 9.84 9.84 4.92 9.84 0.00